As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

Europe’s drug regulator recommended two novel vaccines for influenza alongside updated composition for two COVID-19 vaccines ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

After a lengthy COVID-19 surge this summer, the Bay Area is about to enter the winter respiratory virus season. Explore our ...

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Thursday as the stock market reacts to Taiwan Semiconductor earnings in light of the recent ASML selloff.

The number of people with a medical bill on a credit report is down. But researchers found the decline was smaller in places ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and ...